AstraZeneca targets two billion doses, poor countries with COVID vaccine deals

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in a handful of deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries.